Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Recursion Pharmaceuticals (RXRX) Q1 2025 Earnings
RXRX
28
Feb
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.53
-0.46
-0.4
-0.33
Details
Expected EPS
-0.411429
Actual EPS
-0.53
Surprise EPS
-0.12
Surprise Percent
+28.82%
Description
Recursion Pharmaceuticals (RXRX) has reported earnings of -0.53 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login